Drug Shortage Report for TEVA-VENLAFAXINE XR
| Report ID | 92201 |
| Drug Identification Number | 02275031 |
| Brand name | TEVA-VENLAFAXINE XR |
| Common or Proper name | VENLAFAXINE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 75MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-08-22 |
| Estimated end date | |
| Actual end date | 2020-02-07 |
| Shortage status | Resolved |
| Updated date | 2020-02-08 |
| Company comments | Transitioned to the ACT product |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v24 | 2020-02-08 | English | Compare |
| v23 | 2020-02-07 | French | Compare |
| v22 | 2020-02-07 | English | Compare |
| v21 | 2020-02-07 | French | Compare |
| v20 | 2020-02-07 | French | Compare |
| v19 | 2020-02-07 | English | Compare |
| v18 | 2020-01-30 | French | Compare |
| v17 | 2020-01-30 | English | Compare |
| v16 | 2020-01-30 | English | Compare |
| v15 | 2019-11-21 | French | Compare |
| v14 | 2019-11-21 | English | Compare |
| v13 | 2019-10-24 | French | Compare |
| v12 | 2019-10-24 | English | Compare |
| v11 | 2019-10-17 | French | Compare |
| v10 | 2019-10-17 | English | Compare |
| v9 | 2019-10-03 | French | Compare |
| v8 | 2019-10-03 | English | Compare |
| v7 | 2019-09-12 | French | Compare |
| v6 | 2019-09-12 | English | Compare |
| v5 | 2019-08-23 | English | Compare |